Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1175175 (
SARS
)
19,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A previously undescribed coronavirus (CoV) is the etiologic agent responsible for
severe acute respiratory syndrome
(
SARS
). Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of the
SARS
-CoV Urbani strain, and have rescued molecularly cloned
SARS
viruses (infectious clone
SARS
-CoV) that contained the expected marker mutations inserted into the component clones. Recombinant viruses replicated as efficiently as WT virus and both were inhibited by treatment with the
cysteine proteinase inhibitor
(2S,3S)-transepoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester. In addition, subgenomic transcripts were initiated from the consensus sequence ACGAAC in both the WT and infectious clone
SARS
-CoV. Availability of a
SARS
-CoV full-length cDNA provides a template for manipulation of the viral genome, allowing for the rapid and rational development and testing of candidate vaccines and therapeutics against this important human pathogen.
...
PMID:Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. 1456 23
Severe acute respiratory syndrome
virus (
SARS
-CoV) was the causative agent of the
SARS
outbreaks in 2002-2003. A safer in vitro system is desirable for conducting research on
SARS
-CoV and to screen for antiviral drugs against the virus. Based on the infectious cDNA clone of rSARS-CoV-DeltaE, in which the E gene has been deleted, a safe non-infectious replicon was constructed by replacing the S gene with the enhanced green fluorescent protein (eGFP) gene. Successful replication was achieved as evident from continuous expression of eGFP detected by both fluorescence and Western blot. Treatment with antiviral drugs demonstrated that the replication could be significantly inhibited by 0.4 mg/ml of
cysteine proteinase inhibitor
E-64D, but not by ribavirin. The same replicons containing further deletion of the coding regions for non-structural proteins (nsp) 1, 2 or 16 confirmed previous observation that nsp16, but not nsp1 or nsp2, was essential for efficient viral replication or transcription.
...
PMID:Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function. 1861 43